Pleiotropic role of CCR9/CCL25 signaling in adriamycin-induced cardiomyopathy

Graphical abstract

• Publication year

  2024

• Venue

  Journal of Advanced Research

• Publication date

  2024-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jare.2024.10.018PMID 39442876PMCID 12789724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1/Nrf2 pathway.

  2023cited by this paper
• Discovery and characterization of a novel aryl hydrocarbon receptor inhibitor, IK-175, and its inhibitory activity on tumor immune suppression.

  2022cited by this paper
• Melatonin and Metformin Counteract Cognitive Dysfunction Equally in Male Rats with Doxorubicin-induced Chemobrain.

  2022cited by this paper
• Anti-hepatitis B virus activity of lithospermic acid, a polyphenol from Salvia miltiorrhiza, in vitro and in vivo by autophagy regulation.

  2022cited by this paper
• CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure

  2022cited by this paper
• Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity

  2022cited by this paper
• Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options

  2021cited by this paper
• Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats

  2021influential reference
• The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases

  2021cited by this paper
• Hypoglycemic activity of Origanum vulgare L. and its main chemical constituents identified with HPLC-ESI-QTOF-MS.

  2021cited by this paper
• ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity.

  2021cited by this paper
• Abrogation of CC Chemokine Receptor 9 Ameliorates Ventricular Electrical Remodeling in Mice After Myocardial Infarction

  2021cited by this paper
• Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity

  2021cited by this paper
• CCR9 and CCL25: A review of their roles in tumor promotion

  2020cited by this paper
• CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells

  2020cited by this paper
• Molecular Basis of the Beneficial Actions of Resveratrol.

  2020cited by this paper
• Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12 Which Promotes Lung Fibrosis.

  2020cited by this paper
• Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway

  2020cited by this paper
• Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.

  2020cited by this paper
• EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation: In Vivo and In Vitro Rat Studies.

  2020cited by this paper
• Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies.

  2019cited by this paper
• Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity.

  2019cited by this paper
• Danhong injection mobilizes endothelial progenitor cells to repair vascular endothelium injury via upregulating the expression of Akt, eNOS and MMP-9.

  2019cited by this paper
• FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT

  2019cited by this paper
• Adhesion G protein-coupled receptors: opportunities for drug discovery

  2019cited by this paper
• Traditional Chinese medicine for ischaemic stroke.

  2018cited by this paper
• Anti-inflammatory activities and potential mechanisms of phenolic acids isolated from Salvia miltiorrhiza f. alba roots in THP-1 macrophages.

  2018cited by this paper
• A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

  2018cited by this paper
• AMPK: guardian of metabolism and mitochondrial homeostasis

  2017cited by this paper
• Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.

  2017cited by this paper
• AMPK signalling in health and disease.

  2017cited by this paper
• Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation

  2017cited by this paper
• CCR9 in cancer: oncogenic role and therapeutic targeting

  2016cited by this paper
• G-protein coupled receptors: advances in simulation and drug discovery.

  2016cited by this paper
• C‐C Motif Chemokine Receptor 9 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction

  2016cited by this paper
• Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage.

  2016cited by this paper
• Recent Structural Insights into Cytochrome P450 Function.

  2016cited by this paper
• Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction

  2016cited by this paper
• Beneficial action of resveratrol: How and why?

  2016cited by this paper
• Doxorubicin toxicity changes myocardial energy metabolism in rats.

  2016cited by this paper
• Quercetin Improves Postischemic Recovery of Heart Function in Doxorubicin-Treated Rats and Prevents Doxorubicin-Induced Matrix Metalloproteinase-2 Activation and Apoptosis Induction

  2015cited by this paper
• Lithospermic acid attenuates 1-methyl-4-phenylpyridine-induced neurotoxicity by blocking neuronal apoptotic and neuroinflammatory pathways

  2015cited by this paper
• CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab

  2015cited by this paper
• Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents

  2015cited by this paper
• Anti-oxidative and hepatoprotective effects of lithospermic acid against carbon tetrachloride-induced liver oxidative damage in vitro and in vivo.

  2015cited by this paper
• Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

  2015cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and the Heart

  2014cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and the Heart

  2014cited by this paper
• CYP1A1 Regulates Breast Cancer Proliferation and Survival

  2013cited by this paper
• Lithospermic acid and ischemia/reperfusion injury of the rat small intestine prevention.

  2012cited by this paper
• Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components

  2012cited by this paper
• Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.

  2012cited by this paper
• The chemokine superfamily revisited.

  2012cited by this paper
• Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart.

  2011cited by this paper
• Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals

  2011cited by this paper
• Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply.

  2005influential reference
• Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction

  2003cited by this paper
• Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations

  2003influential reference
• Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

  1997cited by this paper
• A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide.

  1995cited by this paper
• Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbits.

  1993cited by this paper
• Risk factors for doxorubicin-induced congestive heart failure.

  1979cited by this paper
• AMP-activated Protein Kinase (cid:2) 2 and E2F1 Transcription Factor Mediate Doxorubicin-induced Cytotoxicity by Forming a Positive Signal Loop in Mouse Embryonic Fibroblasts and Non-carcinoma Cells *

  year unknowncited by this paper

• Lithospermic Acid Improves Doxorubicin‐Induced Cardiomyopathy Through Sirtuin‐3‐Mediated Deacetylation of p53

  2026cites this paper
• IRF1-Regulated CCL25/CCR9 Promotes Chronic Kidney Disease Progression Through PI3K/AKT-Mediated Oxidative Stress and Inflammatory Response

  2026cites this paper
• Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance

  2025cites this paper
• CCL25 Stabilized by IGF2BP3 Induces Cellular Oxidative Stress to Promote Septic Lung Injury.

  2025cites this paper
• Exploration of the correlation between AHNAK2 and pancreatic cancer and its role in the tumor microenvironment based on bioinformatics: Computational pharmacology

  2025cites this paper